News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
382,309 Results
Type
Article (25940)
Company Profile (60)
Press Release (356309)
Multimedia
Podcasts (26)
Webinars (7)
Section
Business (104263)
Career Advice (450)
Deals (16873)
Drug Delivery (51)
Drug Development (47600)
Employer Resources (47)
FDA (12265)
Job Trends (8443)
News (185940)
Policy (19428)
Tag
Academia (1750)
Accelerated approval (3)
Adcomms (8)
Allergies (74)
Alliances (26751)
ALS (59)
Alzheimer's disease (813)
Antibody-drug conjugate (ADC) (56)
Approvals (12328)
Artificial intelligence (174)
Autoimmune disease (10)
Automation (4)
Bankruptcy (142)
Best Places to Work (6893)
BIOSECURE Act (5)
Biosimilars (36)
Biotechnology (40)
Bladder cancer (60)
Brain cancer (17)
Breast cancer (205)
Cancer (1468)
Cardiovascular disease (122)
Career advice (407)
Career pathing (13)
CAR-T (72)
Cell therapy (206)
Cervical cancer (14)
Clinical research (40580)
Collaboration (451)
Compensation (139)
Complete response letters (9)
COVID-19 (1493)
CRISPR (14)
C-suite (149)
Cystic fibrosis (43)
Data (1607)
Decentralized trials (2)
Denatured (18)
Depression (31)
Diabetes (178)
Diagnostics (3529)
Digital health (11)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (52)
Drug pricing (57)
Drug shortages (21)
Duchenne muscular dystrophy (56)
Earnings (37129)
Editorial (22)
Employer branding (6)
Employer resources (44)
Events (51905)
Executive appointments (456)
FDA (13324)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (413)
Gene editing (40)
Generative AI (11)
Gene therapy (133)
GLP-1 (407)
Government (3041)
Grass and pollen (3)
Guidances (99)
Healthcare (12187)
Huntington's disease (10)
IgA nephropathy (16)
Immunology and inflammation (42)
Indications (19)
Infectious disease (1565)
Inflammatory bowel disease (82)
Inflation Reduction Act (4)
Influenza (27)
Intellectual property (51)
Interviews (40)
IPO (7044)
IRA (19)
Job creations (1840)
Job search strategy (378)
Kidney cancer (7)
Labor market (13)
Layoffs (172)
Leadership (4)
Legal (3632)
Liver cancer (57)
Lung cancer (234)
Lymphoma (101)
Machine learning (4)
Management (17)
Manufacturing (113)
MASH (57)
Medical device (12914)
Medtech (12917)
Mergers & acquisitions (10132)
Metabolic disorders (449)
Multiple sclerosis (56)
NASH (11)
Neurodegenerative disease (51)
Neuropsychiatric disorders (9)
Neuroscience (1159)
NextGen: Class of 2025 (3930)
Non-profit (2822)
Now hiring (17)
Obesity (221)
Opinion (71)
Ovarian cancer (56)
Pain (66)
Pancreatic cancer (56)
Parkinson's disease (91)
Partnered (12)
Patents (119)
Patient recruitment (84)
Peanut (37)
People (34746)
Pharmaceutical (17)
Pharmacy benefit managers (12)
Phase I (11624)
Phase II (17568)
Phase III (14432)
Pipeline (779)
Policy (62)
Postmarket research (1668)
Preclinical (3624)
Press Release (18)
Prostate cancer (78)
Psychedelics (17)
Radiopharmaceuticals (160)
Rare diseases (186)
Real estate (2846)
Recruiting (16)
Regulatory (14238)
Reports (17)
Research institute (1608)
Resumes & cover letters (48)
Rett syndrome (2)
RNA editing (2)
RSV (20)
Schizophrenia (54)
Series A (67)
Series B (52)
Service/supplier (3)
Sickle cell disease (22)
Special edition (4)
Spinal muscular atrophy (102)
Sponsored (13)
Startups (2121)
Stomach cancer (8)
Supply chain (38)
Tariffs (16)
The Weekly (8)
Vaccines (361)
Venture capitalists (13)
Weight loss (142)
Women's health (18)
Worklife (4)
Date
Today (93)
Last 7 days (501)
Last 30 days (1651)
Last 365 days (18357)
2025 (6499)
2024 (19849)
2023 (22736)
2022 (30680)
2021 (32984)
2020 (32190)
2019 (28412)
2018 (21810)
2017 (18906)
2016 (18111)
2015 (21194)
2014 (16023)
2013 (13241)
2012 (14349)
2011 (14622)
2010 (13181)
Location
Africa (354)
Alabama (17)
Alaska (2)
Arizona (119)
Arkansas (10)
Asia (24578)
Australia (3894)
California (3179)
Canada (1250)
China (381)
Colorado (168)
Connecticut (176)
Delaware (123)
Europe (48027)
Florida (569)
Georgia (132)
Idaho (33)
Illinois (365)
India (14)
Indiana (231)
Iowa (3)
Japan (125)
Kansas (74)
Kentucky (12)
Louisiana (8)
Maine (27)
Maryland (647)
Massachusetts (2213)
Michigan (109)
Minnesota (278)
Mississippi (2)
Missouri (52)
Montana (18)
Nebraska (18)
Nevada (36)
New Hampshire (60)
New Jersey (1166)
New Mexico (9)
New York (986)
North Carolina (566)
North Dakota (4)
Northern California (1398)
Ohio (134)
Oklahoma (3)
Oregon (23)
Pennsylvania (859)
Puerto Rico (7)
Rhode Island (24)
South America (520)
South Carolina (24)
Southern California (1221)
Tennessee (80)
Texas (562)
United States (13222)
Utah (115)
Virginia (82)
Washington D.C. (42)
Washington State (232)
West Virginia (3)
Wisconsin (43)
382,309 Results for "soterix medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Soterix Medical Launches MxN-GO EEG System for Wire-free HD-tES and EEG
Soterix Medical Inc., the global leader in non-invasive brain stimulation and synergistic monitoring technologies, announced the launch of MxN-GO EEG, a combined High Definition transcranial Electrical Stimulation and EEG system with a unique untethered design.
April 30, 2024
·
2 min read
Press Releases
Soterix Medical Announces FDA 510(k) Clearance of MEGA-IOM Intraoperative Neuromonitoring System
July 25, 2024
·
2 min read
Drug Development
Soterix Medical announces Phase-2 trial to test at-home tDCS paired with cognitive training as a therapeutic option for long COVID
Soterix Medical Inc. announces the launch of a Phase-2 clinical trial that will evaluate the combination of REMOTE-tDCS and a brain training program for the treatment of long COVID.
August 28, 2023
·
2 min read
Pharm Country
Soterix Medical Announces Patient Recruitment for Parcel-Guided rTMS Depression Trial
Soterix Medical Inc. (SMI), a global leader in non-invasive stimulation and synergistic brain monitoring technologies, announced today that patient recruitment for its treatment resistant depression trial funded by National Institute of Health has begun in New York City.
May 8, 2023
·
2 min read
Pharm Country
Soterix Medical Announces award of Fast Track NIH grant to develop a Parcel-Guided software to improve efficacy of rTMS treatment for Depression
Soterix Medical Inc. (SMI), a global leader in non-invasive neuromodulation and synergistic brain monitoring technologies, announced today that it has been awarded a Fast Track grant from the National Institute of Mental Health (NIMH).
October 13, 2022
·
2 min read
Business
Wise Therapeutics and Soterix Medical Jointly Announce Positive Results of Study Combining Gamified Digital Therapeutics with Neurostimulation Device
Wise Therapeutics (Wise), a developer of game-based digital therapeutics including Personal Zen , and Soterix Medical jointly announced the results of their collaborative study, published in Frontiers in Neuroergonomics.
June 30, 2021
·
2 min read
Press Releases
Tenon Medical(R) Receives Approval for Notice of Allowance from the European Patent Office
March 11, 2025
·
2 min read
Press Releases
Tenon Medical(R) Announces FDA Clearance of Catamaran(R) SI Joint Fusion System for New Indication to Augment Spinal Fusion
March 24, 2025
·
2 min read
Pharm Country
Soterix Medical Announces Expanded Clinical Trials for Alzheimer’s disease and Mild Cognitive Impairment
Soterix Medical Inc. , the global leader in non-invasive stimulation and synergistic brain imaging technologies, is pleased to report expanded clinical trials of its proprietary neuromodulation technologies for Alzheimer’s disease and Mild Cognitive Impairment. Adults over age 65 represent the fastest growing population in the US. Dec
December 24, 2020
·
3 min read
Pharm Country
Soterix Medical study to address post-COVID neurological and psychiatric symptoms using at-home neuromodulation and monitoring
Soterix Medical Inc. (SMI), the global leader in non-invasive stimulation and synergistic brain imaging technologies, announces a new clinical trial of home-based auricular Vagus Nerve Stimulation (taVNS) for individuals who experience post-COVID neuropsychiatric symptoms, like fatigue, headache, or anxiety
January 26, 2021
·
2 min read
1 of 38,231
Next
